Skip to main content
Premium Trial:

Request an Annual Quote

PPI to Shop Health Discovery's Patents for Fields Outside of Healthcare

NEW YORK (GenomeWeb News) – Looking to monetize its patent portfolio, Health Discovery Corp. said today that Patent Profit International will market the firm’s patent portfolio to third parties for applications outside of biomarker discovery and other healthcare applications.
 
HDC said its core support vector machine (SVM) technology could potentially be used in a wide variety of applications including information technology, oil exploration, homeland security, and the automotive industry. The Savannah, Ga.-based firm said that it would retain a royalty-free, worldwide, exclusive license, with the right to grant sublicenses, in all parts of the healthcare field.
 
According to the firm, it holds 15 issued and 19 pending US patents and 14 issued and 16 pending foreign patents. The agreement with PPI “could unlock the value of these intellectual property assets, provide substantial income to HDC and significantly reduce the cost of patent maintenance, prosecution, and litigation,” HDC Chairman and CEO Stephen Barnhill said in a statement.
 
HDC is developing the SVM technology for diagnostic and prognostic applications in prostate cancer, ovarian cancer, breast cancer, endometrial cancer, colon cancer, and leukemia.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.